• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

South Centre Paper Sees IP In Free Trade Agreements Interfering With UN SDGs

27/02/2017 by Kim Treanor for Intellectual Property Watch 1 Comment

A new paper from the intergovernmental South Centre argues that intellectual property provisions in recent free trade agreements would impair countries trying to fulfil the United Nations Sustainable Development Goals. Image Credits: South Centre

Filed Under: IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Development, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, United Nations - other

German-Backed Report Lays Out Strategy For R&D Into New Antibiotics

23/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment

In the face of the lack of attractiveness of investing in research for new antibiotics for the pharmaceutical industry, and the general lack of funding for research and development for novel antibiotics, a new report commissioned by the German Federal Ministry of Health calls for countries to take action. In particular, the report proposes a global union for research and development, a global research fund, and a global launch reward. And access and pricing are key components of the strategy, it says.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, United Nations - other, WHO

US Business, Government Work To Bring Down ‘Dangerous’ UN Panel Report On Access To Medicines – And Change The Debate In Geneva

23/02/2017 by William New, Intellectual Property Watch 3 Comments

Calling it flawed and narrow and seemingly threatened by its contents, the leading United States business group and US government IP specialists are working to limit the impact of a recent United Nations report that made recommendations for the decades-old problem of ensuring affordable medicines reach people when they are under patent in a way that does not threaten innovation. One step in countering the UN report? Change the discourse in Geneva and elsewhere.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, Human Rights, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains, United Nations - other, WIPO, WTO/TRIPS

Side Event On UN High-Level Panel On Access To Medicines Next Week At WTO

23/02/2017 by Intellectual Property Watch 1 Comment

As the World Trade Organization intellectual property committee meeting next week is expected to discuss the report of the United Nations Secretary General’s High-Level Panel on Access to Medicines next week, a group of developing countries is convening a side event to engage in discussion with members of the panel. The report included several direct recommendations to WTO members.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Development, English, Health & IP, Patents/Designs/Trade Secrets, United Nations - other, WTO/TRIPS

Momentum-Building: An Interview With Ruth Dreifuss On High-Level Panel On Access To Medicines

22/02/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

Former Swiss President Ruth Dreifuss, co-chair of the United Nations Secretary General’s High-Level Panel on Access to Medicines, participated in a Geneva event on rare diseases earlier this month. She agreed to answer Intellectual Property Watch’s Catherine Saez about the High-Level Panel report, in particular how it was received by the international community, her take on criticisms that have been voiced, and the importance that the report be discussed at the international level such as the World Health Assembly.

Filed Under: Features, IP Policies, Language, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, United Nations - other, WHO, WTO/TRIPS

Geneva Health Campus: New Home For Global Fund, GAVI, Unitaid In 2018

14/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment

The construction of a new building to host the Global Fund to Fight AIDS, Tuberculosis and Malaria and other key players in the area of global health is well under way in Geneva. The “Campus Santé” (Health Campus) is expected to open its doors at the beginning of 2018. The hosts of the building will be tenants, while the investment costs are borne by Crédit Suisse, a prominent Swiss investment bank.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, English, Finance, Health & IP, Innovation/ R&D, Lobbying, Other International Orgs, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WHO

No Shorter Floor Statements Nor Cap On Agenda Items, Says WHO Board

03/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment

Despite being in a time of tight budgets, the World Health Organization Executive Board meeting which ended this week had its heaviest agenda ever, according WHO Director General Margaret Chan, adding to staff workload and expenses. But the Board finished its work a day early (though after holding three evening sessions), earning praise from Chan. Efforts during the week to make meetings more efficient by limiting agenda items and reducing time allowed for statements fell short. Separately, concerns arose over a leadership advisory group to the WHO director general.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Patents/Designs/Trade Secrets, United Nations - other, WHO

Gates Foundation, KEI Enter Into Official Relations With WHO

31/01/2017 by Catherine Saez, Intellectual Property Watch 3 Comments

The World Health Organization Executive Board ended its meeting one day early today, and agreed to have five new institutions to enter into official relation with the organisation, including the Bill and Melinda Gates Foundation, despite protests from civil society groups, and Knowledge Ecology International, led by activist firebrand Jamie Love. Meanwhile, the WHO is pursuing the implementation of its framework of engagement with non-governmental actors adopted in 2016. WHO members urged the organisation to speedily provide implementation tools such as a register of all such actors. The WHO said all is on track and is expected to be ready by the next World Health Assembly.

Filed Under: IP Policies, Themes, Venues, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, United Nations - other, WHO

Is Gates Foundation, WHO’s Biggest Private Funder, Ineligible To Join WHO?

29/01/2017 by Catherine Saez, Intellectual Property Watch 5 Comments

As the World Health Organization Board prepares to consider candidate institutions to be admitted into official relations with the organisation, some health and public interest groups are raising alarm at what they see as a seeming lack of safeguard against conflicts of interest. Particular concern has been raised over admitting the Bill & Melinda Gates Foundation as an observer because of the Foundation trust’s investments in business ventures such as Coca-Cola, which they see as contrary to health goals. But the Gates Foundation, which is the biggest private donor to the WHO, said the trust is a separate entity from the foundation, and therefore does not represent any conflict of interest.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, United Nations - other, WHO

WHO Director General Candidates Hold Colorful Meeting With The Press

26/01/2017 by William New, Intellectual Property Watch 2 Comments

The three remaining candidates to be director general of the World Health Organization today met at length with UN journalists in the WHO and highlighted their plans for reform including finding new sources of funding for the continually cash-strapped UN agency that now could face threats from the US president to cut US funding.

Filed Under: Features, English, Finance, Health & IP, Patents/Designs/Trade Secrets, United Nations - other, WHO

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 104
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting